Companies Cryptocurrencies
Neurobo Pharmaceuticals Inc
Neurobo Pharmaceuticals Inc
Exchange: NasdaqGS
IPO Date: 05/08/2016
CEO: Mr. Jeong Gu Kang
Biotechnology Healthcare đź”—
  • NRBO
  • 0.3951
  • 10534077
    market cap
  • -0.00490001
If you bought

shares of Neurobo Pharmaceuticals Inc (NRBO) on
You would have made
Old Price $12 Current Price $12

NeuroBo Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat neurodegenerative disorders. The company is headquartered in Ann Arbor, Michigan and currently employs 9 full-time employees. The firm is focused on developing pharmaceuticals to treat neurodegenerative disorders. The firm is addressing unmet needs in patients with Painful Diabetic Neuropathy (PDN) and Alzheimer’s disease. The Company’s product candidate, NB-01, is targeting neuropathic pain with an indication in PDN. The firm also provides NB-02, which is an Alzheimer’s and tauopathies drug.

Address: 200 BERKELEY ST. FL 19 Boston MASSACHUSETTS 02116

Stay updated.